Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Cerebral Angiography - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Cerebral Angiography estimated at US$36.9 Million in the year 2020, is projected to reach a revised size of US$59.5 Million by 2027, growing at a CAGR of 7% over the period 2020-2027.
The U.S. Market is Estimated at $10 Million, While China is Forecast to Grow at 10.7% CAGR
The Cerebral Angiography market in the U.S. is estimated at US$10 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$13.1 Million by the year 2027 trailing a CAGR of 10.7% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
Select Competitors (Total 42 Featured):
- GE Healthcare
- Hitachi Medical Corporation
- Koninklijke Philips N.V.
- Samsung Medison
- Shimadzu Corp.
- Siemens Healthineers
- St. Jude Medical, Inc.
- TERUMO Corporation
- Toshiba Medical Systems Corporation
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/409e0c